Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Justice Oranefo

Clinical Cardiac Electrophysiology Boise, ID Medical Doctor

NPI 1467804302 CMS profile 11283583

287 W Jefferson St, Boise, ID 83702

Open in the dashboard

General payments

$29,779

321 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Justice Oranefo of Boise, ID is reported in the CMS Open Payments database as having received $29,779 across 321 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 62nd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,710 119
2024 General $7,551 84
2023 General $7,285 63
2022 General $5,742 47
2021 General $445 6
2020 General $45 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Justice Oranefo
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Justice Oranefo were reported at $8,710. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Justice Oranefo Clinical Cardiac Electrophysiology median Middle half National median
2019 $0 $2,361 $585–$8,260 $163
2020 $45 $993 $247–$4,351 $114
2021 $445 $1,185 $326–$4,739 $132
2022 $5,742 $2,073 $554–$6,789 $149
2023 $7,285 $2,568 $759–$8,159 $160
2024 $7,551 $2,557 $703–$7,403 $164
2025 $8,710 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Boston Scientific Corporation $10,297 107 payments
  2. Medtronic, Inc. $6,616 64 payments
  3. Biosense Webster, Inc. $4,592 48 payments
  4. Biotronik Inc. $3,567 37 payments
  5. Abbott Laboratories $2,860 41 payments
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $455 9 payments
  7. Respicardia, Inc. $324 3 payments
  8. Philips Electronics North America Corporation $300 4 payments
  9. Medical Device Business Services, Inc. $264 2 payments
  10. AstraZeneca Pharmaceuticals LP $232 2 payments
  11. Other $272 4 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $16,556 275 payments
  2. Travel and Lodging $12,676 42 payments
  3. Education $546 4 payments
Products named General payments · program years 2020–2025
  1. Carto 3 $4,236 41 payments
  2. General - Therapies $2,208 15 payments
  3. Rhythmia Mapping System $1,979 10 payments
  4. VersaCross Access Solution $1,272 7 payments
  5. AVEIR $1,222 10 payments
  6. Plexa ProMRI $716 1 payment
  7. Sentus $716 1 payment
  8. Edora 8 DR-T $716 1 payment
  9. Acticor 7 VR-T DX $716 1 payment
  10. Solia $716 1 payment
  11. Other $7,915 153 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

53

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$1,200

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

0%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amiodarone Hcl Generic 16 $670
Flecainide Acetate Generic 13 $369
Famotidine Generic 12 $92
Pantoprazole Sodium Generic 12 $69

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$25,584

Medicare's payments for the services billed

Medicare patients

429

Average age 75

Services billed

599

214 women, 215 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Atrial fibrillation 36%
Diabetes 35%
Ischemic heart disease 33%
Chronic kidney disease 32%
Depression 30%
Heart failure 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

321 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record